This section details the equations that define and support the optional PBPKPlus™ model that Simulations Plus developed for modeling multiple PD effects for any drug record in a database. See:
-
For details about the internal standards that were used to define the equations in this section, see Equation Standards.
-
The PD effect can also be referred to as the pharmacological response, or just the response, and is abbreviated as E or R, respectively. These terms and abbreviations are used interchangeably in this chapter.
Direct Response PD Model Equations
Unless explicitly noted otherwise, “E” represents both a stimulated and an inhibited PD effect. If the PD effect is solely inhibition, then “I” is used.
Equation 3-1: Linear model, observed PD effect versus concentration
where:
|
Variable |
Definition |
|
|
The PD effect. |
|
|
The total or unbound concentration of the drug in plasma. |
|
|
The slope of the plot of E versus Cp. |
Equation 3-2: Linear model, observed PD effect versus concentration with baseline
Equation 3-3: Log Linear model
Equation 3-4: Emax model, PD effect is stimulated
Equation 3-5: Emax model, PD effect is inhibited
where:
|
Variable |
Definition |
|
|
The PD effect. |
|
|
The baseline of the PD effect. |
|
|
The maximum PD response. |
|
|
The total or unbound concentration of the drug in plasma. |
|
|
The concentration of the drug at 50% of the maximum PD response. |
Equation 3-6: Hill equation
where:
|
Variable |
Definition |
|
|
The Hill parameter. |
|
|
The PD effect. |
|
|
The baseline of the PD effect. |
|
|
The maximum PD response. |
|
|
The total or unbound concentration of the drug in plasma. |
|
|
The concentration of the drug at 50% of the maximum PD response. |
Indirect Response PD Model Equations
Equation 3-7: Drug transfer rate for the Effect Compartment model
where:
|
Variable |
Definition |
|
|
The amount of drug in the plasma compartment. |
|
|
The amount of drug in the effect compartment. |
|
|
The drug transfer rate constant from the plasma compartment to the effect compartment. |
|
|
The drug transfer rate constant from the effect compartment to the plasma compartment. |
Equation 3-8: Drug mass in the Effect Compartment model
where:
|
Variable |
Definition |
|
|
The rate of distribution of drug from the plasma compartment to the effect compartment, referred to as the inter-compartmental distribution rate. |
|
|
The total or unbound concentration of drug in the plasma compartment. |
|
|
The total or unbound concentration of drug in the effect compartment. |
Equation 3-9: Rate of change of PD effect variable in the absence of drug
Under steady state conditions, kin = koutR0, where R0 is the baseline PD effect.
Equation 3-10: Standard inhibitory equation
Equation 3-11: Change in PD effect variable over time, Class I indirect response model
Equation 3-12: Change in PD effect variable over time, Class II indirect response model
Equation 3-13: Standard stimulatory equation
Equation 3-14: Change in PD effect variable over time, Class III indirect response model
Equation 3-15: Change in PD effect variable over time, Class IV indirect response model
Equation 3-16: Rate of change in quantity of target cells (Cell killing model, phase non-specific)
where:
|
Variable |
Definition |
|
|
The cell growth rate constant, which is the difference between the natural mitotic rate and physiologic degradation. |
|
|
The rate of the irreversible reaction. |
Equation 3-17: Initial state of the system, BKG model
where:
|
Variable |
Definition |
|
|
The initial number of bacteria. |
|
|
The percent of pre-existing antibiotic-resistant bacteria. |
|
|
The percent of bacterial cells that are in the resting state. |
|
|
Resting state of sub-population 1. |
|
|
Resting state of sub-population 2. |
Equation 3-18: Transfer rate from S population to R population, BKG model
where:
|
Variable |
Definition |
|
|
The maximum number of bacteria in the stationary phase. |
|
|
The growth rate constant for antibiotic-susceptible bacteria. |
|
|
The rate constant for bacterial natural death. |
|
|
The total number of bacteria across all sub-populations. |
Equation 3-19: Effect of the drug on each bacterial sub-population, BKG model
where kdrug,mut is the growth rate constant for pre-existing antibiotic-resistant bacteria.
Equation 3-20: Effect of an antibiotic drug with Power model or Sigmoidal model
where:
|
Variable |
Definition |
|
|
The drug concentration. |
|
|
The Hill factor in the drug-effect relationship. |
|
|
The maximum kill rate constant. |
|
|
The concentration of the drug that produces 50% of Emax. |
|
|
The shift in the concentration of the drug that is required for the drug to have the same effect on the mutant bacteria as it does on the antibiotic-susceptible bacteria, |
Equation 3-21: Calculations for a precursor-dependent indirect response model
where:
|
Variable |
Definition |
|
|
The amount of precursor. |
|
|
The zero order rate constant for precursor production. |
|
|
The first order rate constant for response production. |
|
|
The first order rate constant for loss of precursor. |
|
|
The first order rate constant for loss of response. |
|
|
The inhibition (Class VII) or stimulation (Class VIII) of precursor production. |
|
|
The inhibition (Class V) or stimulation (Class VI) of response production. |
Equation 3-22: Incorporating a circadian rhythm in the baseline response, precursor-dependent indirect response model
where:
|
Variable |
Definition |
|
|
The mean production of response rate. |
|
|
The amplitude of rate. |
|
|
The time of occurrence of the peak production rate. |